单中心胶质瘤手术中术中变量作为30天再入院预测因素的分析
该单中心回顾性研究分析了290例由同一术者行胶质瘤手术患者的术中记录,采用单因素与逐步回归分析术中变量对30天再入院率的影响,并构建预测模型。多因素分析显示,术毕低体温(OR 0.28,95%CI [0.09, 0.84])、高血压时间>15分钟(OR 2.85,95%CI [1.21, 6.75])及术前KPS(OR 0.63,95%CI [0.41, 0.98])与30天再入院率显著相关。模型交叉验证总体准确率89.7%,特异度99.6%,AUC 0.763。作者认为术中危险因素可能有助于风险分层并改善术后随访,需前瞻性验证。
要点
- 术毕低体温(OR 0.28,95%CI [0.09, 0.84])与30天再入院率显著相关。
- 高血压时间>15分钟(OR 2.85,95%CI [1.21, 6.75])与30天再入院率显著相关。
- 术前KPS(OR 0.63,95%CI [0.41, 0.98])与30天再入院率显著相关。
核心结论
- 术中危险因素可能有助于以较高准确度对患者进行风险分层并改善术后随访。
- 应关注高血压持续时间和术毕最终体温,因其为可能可干预且似乎与30天再入院率高度相关的因素。
- 作者认为需对本模型进行前瞻性验证,以评估其作为筛查工具识别胶质瘤手术后30天内再入院高风险患者的潜力。
研究设计与样本
- 单中心回顾性研究,评估290例由同一术者行胶质瘤手术患者的术中记录。
- 术中变量(包括麻醉相关因素)通过单因素与逐步回归分析评估对30天再入院率的影响。
- 构建预测模型评估预测再入院的能力,并采用留一交叉验证进行验证。
主要发现
- 多因素分析中,术毕低体温(OR 0.28,95%CI [0.09, 0.84])、高血压时间>15分钟(OR 2.85,95%CI [1.21, 6.75])及术前KPS(OR 0.63,95%CI [0.41, 0.98])与30天再入院率显著相关(卡方统计量 vs 常数模型25.2,p<0.001)。
- 模型交叉验证总体准确率89.7%,特异度99.6%,受试者工作特征曲线下面积(AUC)0.763。
关键数值与推荐
- 术毕低体温:OR 0.28,95%CI [0.09, 0.84]。
- 高血压时间>15分钟:OR 2.85,95%CI [1.21, 6.75]。
- 术前KPS:OR 0.63,95%CI [0.41, 0.98]。
- 模型卡方统计量 vs 常数模型25.2,p<0.001。
- 交叉验证总体准确率89.7%,特异度99.6%,AUC 0.763。
临床怎么用
- 作者认为术中危险因素可能有助于以较高准确度对患者进行风险分层并改善术后随访。
- 作者建议关注高血压持续时间和术毕最终体温,因其为可能可干预且似乎与30天再入院率高度相关的因素。
- 作者认为需前瞻性验证本模型,以评估其作为筛查工具识别胶质瘤手术后30天内再入院高风险患者的潜力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Reducing the time from surgery to adjuvant chemoradiation, by decreasing unnecessary readmissions, is paramount for patients undergoing glioma surgery. The effects of intraoperative risk factors on 30-day readmission rates for such patients is currently unclear. We utilized a predictive model-driven approach to assess the impact of intraoperative factors on 30-day readmission rates for the cranial glioma patient. METHODS: Retrospectively, the intraoperative records of 290 patients who underwent glioma surgery at a single institution by a single surgeon were assessed. Data on operative variables including anesthesia specific factors were analyzed via univariate and stepwise regression analysis for impact on 30-day readmission rates. A predictive model was built to assess the capability of these results to predict readmission and validated using leave-one-out cross-validation. RESULTS: In multivariate analysis, end case hypothermia (OR 0.28, 95% CI [0.09, 0.84]), hypertensive time > 15 min (OR 2.85, 95% CI [1.21, 6.75]), and pre-operative Karnofsky performance status (KPS) (OR 0.63, 95% CI [0.41, 0.98] were identified as being significantly associated with 30-day readmission rates (chi-squared statistic vs. constant model 25.2, p < 0.001). Cross validation of the model resulted in an overall accuracy of 89.7%, a specificity of 99.6%, and area under the receiver operator curve (AUC) of 0.763. CONCLUSION: Intraoperative risk factors may help risk-stratify patients with a high degree of accuracy and improve postoperative patient follow-up. Attention should be paid to duration of hypertension and end-case final temperature as these represent potentially modifiable factors that appear to be highly associated with 30-day readmission rates. Prospective validation of our model is needed to assess its potential for implementation as a screening tool to identify patients undergoing glioma surgery who are at a higher risk of post-operative readmission within 30 days.
引用
- Cajigas I, Mahavadi AK, Shah AH, et al. Analysis of intra-operative variables as predictors of 30-day readmission in patients undergoing glioma surgery at a single center. J Neurooncol. 2019. PMID: 31642024. doi:10.1007/s11060-019-03317-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。